# Cannabinoid Pain Relief: Evidence-Based Clinical Review

> **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637)
> **Publisher:** CED Clinic (https://cedclinic.com)
> **Canonical URL:** https://cedclinic.com/cannabinoid-pain-relief-evidence-based-clinical-review/
> **Published:** 2026-04-25T13:58:50-04:00 | **Last Modified / Clinically Audited:** 2026-09-27T22:59:43-04:00
> **Clinical Summary:** Clinical Takeaway Clinical Takeaway Cannabinoids directly affect sodium channels involved in pain signal transmission in nerves, which provides a potential mechanism for their analgesic effects. This systematic review consolidates evidence that cannabinoid compounds can modulate these ion channels, supporting the biological basis for pain reduction observed in clinical settings. Understanding this mechanism helps explain why [&hellip;]

---

#### Clinical Takeaway

Clinical Takeaway

Cannabinoids directly affect sodium channels involved in pain signal transmission in nerves, which provides a potential mechanism for their analgesic effects. This [systematic review](https://cedclinic.com/cannabinoid-safety-efficacy-mental-health-study/) consolidates evidence that cannabinoid compounds can modulate these ion channels, supporting the biological basis for [pain reduction](https://cedclinic.com/glp-1-receptor-agonists-pain-management/) observed in clinical settings. Understanding this mechanism helps explain why cannabinoids may be effective for certain pain conditions and guides development of targeted [pain management](https://cedclinic.com/cbd-cbg-topicals-for-eczema/) approaches.

### #18 Electrophysiological modulation of pain‑related sodium channels by cannabinoids: a systematic review.

**Citation:** Castro Samuel Gonçalves et al. *Electrophysiological modulation of pain‑related sodium channels by cannabinoids: a systematic review.* Journal of [cannabis research](https://cedclinic.com/pediatric-cannabis-certification-care-children/). 2026. PMID: 41987259.

**Study type:** Journal Article, Systematic Review  | 

**Topic area:** Cannabidiol  | 

**CED Score:** 10

Design: 5 Journal: 0 N: 0 Recency: 3 Pop: 2 Human: 0 Risk: 0

**Quality Gate Alerts:**
- No human data
- No abstract

**Abstract:** Abstract not available.

 | 

[View on PubMed ↗](https://pubmed.ncbi.nlm.nih.gov/41987259/)[DOI ↗](https://doi.org/10.1186/s42238-026-00436-6)

 
 
 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 
 
 Physician-Led, Whole-Person Care
 A doctor who takes the time to truly understand you.
 Personal care that starts with listening and is guided by experience and ingenuity.
 
 Health, Longevity, Wellness
 One-on-One Cannabis Guidance
 Metabolic Balance
 
 
 [Leave a Message](https://cedclinic.com/contact/)
 [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/)
 [Medical Consulting](https://cedclinic.com/book/)
 [Cannabis Care](https://cedclinic.com/book/)
 
 
 
 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 
 

 

### Related

---

### Verification & Medical Governance

- **Lead Clinical Author:** Benjamin Caplan, MD
- **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House).
- **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`).
- **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/).
- **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637).
- **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).
